A B Sugraliev - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Klinicheskaia Meditsina|June 29, 2002

[Rheumatic manifestations of Takayasu's disease]A B Sugraliev, E L Nasonov, G G Arabidze, et al.

Klinicheskaia Meditsina|January 1, 1996

[Clinicoimmunological characteristics of aneurysmic lesion in nonspecific aortic arteritis]A B Sugraliev, G G Arabidze, E L Nasonov, et al.

Kardiologiia|October 1, 1991

[Cardiolipin antibodies in non-specific aortic arteritis]E L Naconov, G G Arabidze, A B Sugraliev, et al.

Kardiologiia|January 1, 1992

[Serum lipoprotein (A) in patients with myocardial infarction and aortoarteritis]M G Tvorogova, L E Niiazova, S V Nikitin, et al.

Kardiologiia|June 10, 2020

[The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange]G P Arutyunov, N A Koziolova, E I Tarlovskaya, et al.

Terapevticheskii Arkhiv|December 21, 2020

[The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2]G P Arutiunov, E I Tarlovskaia, N A Koziolova, et al.

Kardiologiia|September 12, 2024

Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries)G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.

Kardiologiia|January 25, 2021

[International register "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)"]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.

Kardiologiia|October 29, 2021

Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.

Terapevticheskii Arkhiv|October 26, 2022

[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Klinicheskaia Meditsina|June 29, 2002

[Rheumatic manifestations of Takayasu's disease]A B Sugraliev, E L Nasonov, G G Arabidze, et al.

Klinicheskaia Meditsina|January 1, 1996

[Clinicoimmunological characteristics of aneurysmic lesion in nonspecific aortic arteritis]A B Sugraliev, G G Arabidze, E L Nasonov, et al.

Kardiologiia|October 1, 1991

[Cardiolipin antibodies in non-specific aortic arteritis]E L Naconov, G G Arabidze, A B Sugraliev, et al.

Kardiologiia|January 1, 1992

[Serum lipoprotein (A) in patients with myocardial infarction and aortoarteritis]M G Tvorogova, L E Niiazova, S V Nikitin, et al.

Kardiologiia|June 10, 2020

[The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange]G P Arutyunov, N A Koziolova, E I Tarlovskaya, et al.

Terapevticheskii Arkhiv|December 21, 2020

[The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2]G P Arutiunov, E I Tarlovskaia, N A Koziolova, et al.

Kardiologiia|September 12, 2024

Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries)G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.

Kardiologiia|January 25, 2021

[International register "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)"]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.

Kardiologiia|October 29, 2021

Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.

Terapevticheskii Arkhiv|October 26, 2022

[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.

Pageof 2